Patents by Inventor Xi Zhao-Wilson
Xi Zhao-Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10016476Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.Type: GrantFiled: September 17, 2015Date of Patent: July 10, 2018Assignee: BioMarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Publication number: 20160000852Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.Type: ApplicationFiled: September 17, 2015Publication date: January 7, 2016Inventor: Xi Zhao-Wilson
-
Patent number: 9138453Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.Type: GrantFiled: October 13, 2014Date of Patent: September 22, 2015Assignee: BioMarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Publication number: 20150104393Abstract: A composition comprising an effective amount of a combination of mitochondrial nutrients sufficient to affect mitochondrial function. A method of affecting an aging process in a subject comprising administering to a subject an effective amount of a combination of mitochondrial nutrients sufficient to affect an aging process. A method of identifying a combination of mitochondrial nutrients sufficient to affect an aging process in a subject, the method comprising: administering a combination of mitochondrial nutrients to a subject; and determining whether the mitochondrial nutrients affect an aging process in the subject.Type: ApplicationFiled: October 13, 2014Publication date: April 16, 2015Inventor: Xi Zhao-Wilson
-
Patent number: 8692051Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: GrantFiled: April 29, 2013Date of Patent: April 8, 2014Assignee: BioMarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Publication number: 20130239235Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: ApplicationFiled: April 29, 2013Publication date: September 12, 2013Applicant: BioMarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Patent number: 8436224Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: GrantFiled: June 6, 2011Date of Patent: May 7, 2013Assignee: BioMarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Patent number: 8403844Abstract: Methods and systems for monitoring interventions and/or a subject, such as a human patient. One exemplary embodiment of a method includes measuring at least one biological parameter of a subject, determining a biological state from the measuring, administering (after the measuring) an intervention which includes a caloric restriction (CR) mimetic to the subject and measuring, after the administering, the at least one biological parameter and determining a later biological state from the measuring after the administering.Type: GrantFiled: March 16, 2006Date of Patent: March 26, 2013Assignee: BioMarker Pharmaceuticals, Inc.Inventors: Xi Zhao-Wilson, Paul C. Watkins, Joseph M. Dhahbi
-
Publication number: 20120030777Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: ApplicationFiled: June 6, 2011Publication date: February 2, 2012Applicant: Biomarker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Patent number: 7960605Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of the another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: GrantFiled: March 17, 2006Date of Patent: June 14, 2011Assignee: BioMaker Pharmaceuticals, Inc.Inventor: Xi Zhao-Wilson
-
Publication number: 20070219418Abstract: Methods and systems for monitoring interventions and/or a subject, such as a human patient. One exemplary embodiment of a method includes measuring at least one biological parameter of a subject, determining a biological state from the measuring, administering (after the measuring) an intervention which includes a caloric restriction (CR) mimetic to the subject and measuring, after the administering, the at least one biological parameter and determining a later biological state from the measuring after the administering.Type: ApplicationFiled: March 16, 2006Publication date: September 20, 2007Inventors: Xi Zhao-Wilson, Paul Watkins, Joseph Dhahbi
-
Publication number: 20070220619Abstract: Methods for treating neurological diseases and for testing Caloric Restriction (CR) mimetics or CR mimetic candidates. In one exemplary method, a CR mimetic candidate is administered to a transgenic animal and the effects of the administering are determined; the transgenic animal includes an added gene from another type of animal or a modified gene which is designed to produce a disease or ailment of the another type of animal, and the method seeks to determine whether the CR mimetic candidate improves the disease or ailment. Methods relating to neurological disease and other methods relating to CR mimetic testing are also described.Type: ApplicationFiled: March 17, 2006Publication date: September 20, 2007Inventor: Xi Zhao-Wilson